The 1,850-square-foot house was built in 2000 in the Bellevue Central neighborhood.
Chan-Hui is director for in vitro pharmacology and assay development at Spaltudaq Corp., a biotechnology investment and development company.
He previously has been director of enabling applications at ACLARA Biosciences Inc. and a scientist of inflammation at Amgen Inc. He also has been a post-doctoral scientist of cellular interactions at Bristol-Myers Squibb.
He received his Ph.D. in immunology and molecular cellular biology in 1988 from the University of British Columbia and completed his post-doctoral fellow in cellular adhesion biology from Harvard Medical School.
According to BlockShopper.com, there have been 773 home sales in Bellevue during the past 12 months, with a median sales price of $480,000.
Address: 2485 132nd Avenue SE
Buyer(s): Po-Ying Chan-Hui
Seller(s): Carol Ann Stephenson
Sale date: Oct. 30, 2009